http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02128696-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1374dd16777534b65ad4422333245af8
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
filingDate 1988-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e73595ea121001f29a4bafc550f6b5bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1140fe5228c2fe6e74684110a15da115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad260c19afd2a4635c0ade016fa1281f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50bf2573d87ec93fd2060f88ec3b2b30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f64e3fdfb5652ebcbb5329be5ed7ae9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90ce2417115decaceff6584222f523a2
publicationDate 1990-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H02128696-A
titleOfInvention Novel physiologically active polypeptide
abstract NEW MATERIAL:A physiologically active polypeptide losing 1-12 amino acid residues on amino end side and having a sequence containing substitution of 157th Leu to Phe or a polypeptide linking Met to the above-mentioned polypeptide in an amino acid sequence expressed by the formula and shown by sequence from 1st Val to 157th Leu. n USE: An antiulcer agent. n PREPARATION: For example, in an amino acid sequence expressed by the formula, a recombinant microbial cell transformed by a recombinant plasmid containing a DNA domain coding a physiologically active polypeptide losing 1-12 amino acid residues on amino end side in an amino acid sequence expressed by the formula and having a sequence containing substitution of the 157th Leu to Phe or polypeptide linking Met to amino ends of the above-mentioned polypeptide is cultured and the aimed product is separated from the cultured material to provide the physiologically active polypeptide. n COPYRIGHT: (C)1990,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7133776-B2
priorityDate 1988-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401

Total number of triples: 26.